-
Stocks mostly rise tracking earnings, US-Iran hopes
-
Alarm at German airport after drone found near Ukrainian plane, mid-air incident
-
Pakistan team reaches base camp with body of renowned climber killed in avalanche
-
Salah arrives in Turkey for Trabzonspor talks
-
Ceuta warns of 'unsustainable' situation for child migrants after influx
-
Embattled FIFA chief Infantino holds emergency talks with directors
-
SpaceX rocket stage believed to have slammed into Moon
-
Russian barrage on Kyiv kills 17 as Ukraine fails to down single missile
-
India monsoon floods, landslides kill more than 100 since July: officials
-
'Lost': Migrants despair after Britain expels them back to France
-
South Korea pro baseball league cancels games over heatwave
-
Cathay Pacific's profit soars 71% despite Iran war driving up fuel costs
-
Taiwan probes 17 China-funded firms over high-tech talent poaching
-
Russian barrage on Ukraine kills 15, wounds dozens more
-
Trump warns Iran to open Hormuz or get 'hit very hard'
-
South Korea police raid Starbucks HQ over 'Tank Day' fiasco
-
Factories shed workers in Bangladesh garment sector
-
Tech back in fashion as Asian markets extend rebound
-
North Korea warns of 'military options' over Japan rearmament
-
Total eclipse gives scientists chance to probe Sun's mysteries
-
Tiny light, big dream: Harvesting power from soil in Japan
-
What to know about the total solar eclipse on August 12
-
Trump admin to review 'closed' AI models before release: reports
-
'Like the end of the world': the eclipse chasers flocking to Spain
-
De Minaur fights past Duckworth in all-Aussie Montreal battle
-
Taiwan begins military drills as China pressure grows
-
High bills, cheap panels drive a Philippine solar surge
-
UK mansion where 'listeners' spied on Nazi generals becomes museum
-
Russian barrage on Ukraine kills 2, wounds dozens more
-
Sabalenka tops Uchijima in WTA Toronto opener
-
RE Royalties Announces Third Investment in Solaris Energy's Portfolio and Letter of Intent for Expanded Royalty Partnership for a Further US$62.7 Million
-
Alcaraz withdraws from Cincinnati Masters with wrist injury
-
Kgatlana strikes as South Africa reach WAFCON quarter-finals
-
SpaceX revenue jumps 92% in first earnings report, but shares slide
-
Pakistan close on series-levelling win against West Indies
-
US eyes Hormuz deal 'today or tomorrow' as ship sinks in Red Sea
-
Paramount CEO says politics fueling Warner Bros. merger battle
-
SpaceX revenue jumps 92% in first earnings report
-
Trump's sale of access to Truth Social raises eyebrows
-
New commissioner Berg wants to take MLS to 'next level'
-
SpaceX rocket stage expected to slam into Moon
-
Colombian ex-guerrillas fear for future under hardline president
-
US hopeful Hormuz strait deal will be done 'today or tomorrow'
-
Tsitsipas comeback continues with Montreal first-round win
-
Michigan primary puts Democratic divide on the ballot
-
Swiatek fends off Bejlek to reach Toronto third round
-
South Africa captain Kolisi to make Test return in Argentina
-
Reusser romps to overall lead at Tour de France Femmes
-
Cuba's famed resilience comes at a growing mental cost
-
McDonald's reports slower US sales in 2nd quarter
US judge orders Purdue Pharma to pay billions ahead of bankruptcy
A US federal judge on Tuesday sentenced OxyContin-maker Purdue Pharma to pay billions of dollars over its role in the opioid crisis, ahead of upcoming bankruptcy proceedings and its dissolution.
The criminal sentencing caps off years of legal battles and paves the way for Purdue and its former owners, the Sackler family, to pay more than $8 billion as part of a settlement.
Between 1999 and 2023, around 806,000 people died from opioid overdoses in the United States, according to the Centers for Disease Control and Prevention.
Purdue and other opioid makers and distributors are accused of encouraging free-wheeling prescription of painkillers like OxyContin starting in the 1990s, while hiding how addictive the drugs are.
Last year, several US states reached a settlement with Purdue and the Sackler family, with a bankruptcy plan that will see funds routed to affected communities and individuals.
The total amount to be paid in fines, forfeitures and penalties surpasses $8 billion.
The company is set to be dissolved on May 1, with the remnants becoming Knoa Pharma, a public benefit company that will provide opioid use disorder treatments and overdose reversal medicines.
For more than six hours on Tuesday, US Judge Madeline Cox Arleo listened to dozens of victims and their families testify about the impact Purdue Pharma and the opioid epidemic had on them.
She then ordered Steve Miller, Purdue Pharma's board chair, to apologize to them.
During the proceedings to resolve a Department of Justice probe and clear the way for the settlement, Arleo read the names of more than 200 victims who had submitted written statements before the hearing.
"These people are not statistics in an epidemiological study," she said, adding that the testimonies were "heartbreaking."
The judge also apologized on behalf of the US government, saying it had "failed" to protect the public from Purdue Pharma, whose practices were "driven by greed" and had a "corporate strategy much like a criminal enterprise."
While many testifying on Tuesday urged the settlement agreement to be rejected -- in part because it protects the Sackler family from criminal prosecution -- Arleo called it the "best route I see among the options before me."
She urged the lawyers handling the bankruptcy proceedings to honor their promises of compensation.
For many people, opioid addiction begins with prescribed pain pills, such as OxyContin, before they increase their consumption and eventually turn to illicit drugs such as heroin and fentanyl, an extremely powerful synthetic opioid.
M.A.Vaz--PC